Related Experiment Video
Updated: Mar 8, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
How expensive is a cardioprotective diet? Analysis from the CRESSIDA study
Dianne P Reidlinger1, Thomas Ab Sanders2, Louise M Goff2
11Faculty of Health Sciences and Medicine,Bond University,2 Promethean Way, Robina,QLD 4226,Australia.
Objective:
To determine whether a cardioprotective dietary intervention based on UK dietary guidelines was more expensive than a conventional UK diet.
Design:
Cost analysis of food records collected at baseline and after a 12-week dietary intervention of a cardioprotective diet v. conventional UK diet.
Setting:
A randomized controlled dietary intervention study (CRESSIDA; ISRCTN 92382106) investigating the impact of following a diet consistent with UK dietary guidelines on CVD risk.
Subjects:
Participants were healthy UK residents aged 40-70 years. A sub-sample of participants was randomly selected from those who completed the cardioprotective dietary intervention (n 20) or the conventional UK dietary intervention (n 20).
Results:
Baseline diet costs did not differ between groups; mean daily food cost for all participants was £6·12 (sd £1·83). The intervention diets were not more expensive: at end point the mean daily cost of the cardioprotective diet was £6·43 (sd £2·05) v. the control diet which was £6·53 (sd £1·53; P=0·86).
Conclusions:
There was no evidence that consumption of a cardioprotective diet was more expensive than a conventional dietary pattern. Despite the perception that healthier foods are less affordable, these results suggest that cost may not be a barrier when modifying habitual intake and under tightly controlled trial conditions. The identification of specific food groups that may be a cost concern for individuals may be useful for tailoring interventions for CVD prevention for individuals and populations.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy II: Dilated Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease V: Interprofessional Care

